Santen PharmaceuticalSANTEN PHARMACEUTICAL CO.,LTD.4536東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +8.2% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | 9.1% | —× | — |
| 2019 | 13.7% | 0.60× | 8.2% | 1.33× | 10.9% |
| 2022 | — | —× | 5.9% | —× | — |
| 2023 | — | —× | -3.4% | —× | — |
| 2024 | 8.8% | 0.70× | 6.2% | 1.40× | 8.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Revenue | 224,942 | 234,026 | 266,257 | 279,037 | 301,965 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 39,261 | 43,117 | 35,616 | -5,799 | 29,874 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | 35,247 | 31,954 | 27,218 | -14,948 | 26,642 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥69.3B | ¥70.8B | ¥83B | ¥57.9B | ¥94.6B |
| Total assets | ¥388.5B | ¥391.2B | ¥460B | ¥421.2B | ¥435.7B |
| Net assets | — | ¥292.6B | — | — | ¥305.4B |
EDINET (FSA Japan)
有価証券報告書－第114期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第111期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第110期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第109期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.